fashion -WSS

fashion

author：hotspot 2025-10-02 23:30:34 - browse：2484

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Sanofi seeks simpler, safer CRISPR sickle cell cure

WSS

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

As digital health tech proliferates, a new institute aims to cut through hype

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

WHO calls for emergency meeting on new China virus, as cases spread

Why Marc Tessier

What is artificial intelligence? Experts weigh in

leisure time

fashion

focus

Guidelines to prevent youth baseball injuries need more muscle

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

In age of alternative facts, a scholarly course on calling out crap

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Bright Health sells Medicare Advantage business to Molina

How Brent Saunders' Allergan experiment failed

New air purifier tech could be key to improving indoor air quality

Hey, doctors: Don't be no

Continuity nursing helped my family in our darkest PICU moments

At Orexo, a ‘turning point’ for everything but digital health

Wikipedia

Reframing the conversation around gain

Custom gene therapy hints at new path for rare disease treatments

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Sanofi seeks simpler, safer CRISPR sickle cell cure

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Listen: Wegovy in the brain & pivotal Alzheimer's data

hotspot

hotspot

knowledge

hotspot